How Are Progressive ILD and PH‑ILD Treated?
What treatment options exist for progressive interstitial lung disease and pulmonary hypertension‑ILD? Jared Freitas, MD, Assistant Professor Division of Pulmonary, Critical Care and Sleep Medicine at UF Health Shands Hospital, explains current therapies. He reviews anti‑fibrotic drugs (nintedanib/Ofev, pirfenidone/Esbriet), the newer PDE4B inhibitor nirandromolast (JAZZCAID) and inhaled treprostinil (Tyvaso) for PH‑ILD, plus when immunosuppression, combination therapy, and close monitoring are considered.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.